NEW YORK, NY / ACCESSWIRE / May 24, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Alere, Inc. ("Alere" or "the Company") (NYSE: ALR). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Alere, Inc. securities during the period between May 9, 2013 and April 20, 2016 inclusive (the "Class Period").
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").
Alere Inc. is a provider of health information through diagnostic tests for infections such as HIV, tuberculosis, malaria and dengue. The Company operates through professional diagnostics, patient self-testing, consumer diagnostics and, corporate and other segments.
The Complaint alleges that throughout the Class Period, Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Alere inappropriately related revenue in violation of Generally Accepted Accounting Principles; (2) as a result, Alere's quarterly and annual SEC filings would be late; (3) as a result of the abovementioned, Alere's prearranged merger with Abbott Laboratories would be questionable; (4) Alere lacked satisfactory internal accounting and financial controls; and (5) as a result, Alere's public statements were materially false and misleading at all relevant times.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint and join the action, visit the firm's website: http://www.bgandg.com/#!alr/s1i4l. To discuss this action, or have any questions, please contact Peretz Bronstein, Esq. or Eitan Kimelman, Investor Relations Coordinator of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Alere you have until June 20, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC